Anti-Mouse TREM2 (178) In Vivo Antibody - LALAPG

Mouse

TREM2

>1.0 mg/ml

Mouse IgG2a

Mouse

ICH3002

Q99NH8

TREM2 is an innate immune receptor on myeloid cells, particularly microglia, that regulates phagocytosis, survival, and inflammatory responses and is a focus of neurodegeneration research. The recombinant mouse IgG2a clone 178.0, engineered with LALAPG Fc-silencing mutations to minimise effector function, recognises mouse TREM2 and is validated for blocking, ELISA, functional assays, flow cytometry, and in vivo work. This 178.0 LALAPG antibody is supplied low in endotoxin for in vivo use and produced in scalable milligram to gram quantities for bulk and high-throughput laboratories. It is a non-therapeutic, research-use-only reagent offering reproducible results for microglial and TREM2-pathway studies.

Triggering receptor expressed on myeloid cells 2

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –20°C or –80°C. Avoid Repeated Freeze Thaw Cycles.

Blocking, ELISA, Functional Assays, Flow Cytometry, in vivo

This antibody is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.